NPM1 and acute myeloid leukemia: Nucleophosmin (NPM1) mutations are considered as one of the most common genetic alteration in acute myeloid leukemia (AML) [116], and aberrant cytoplasm-dislocated NPM1 mutant is a distinct biological characterization of this disease [117,118].